Navigating The FDA’s 2025 Cybersecurity Update? Maven Has Your Back

Medical device cybersecurity is no longer optional, it’s a regulatory and patient safety priority. With the FDA’s June 2025 cybersecurity guidance update, manufacturers are now expected to adopt a lifecycle-based, proactive security approach.

For many organizations, the challenge isn’t just understanding the guidance, it’s implementing it effectively across systems, teams, and products.

At Maven Regulatory Solutions, we simplify complexity helping you turn regulatory expectations into practical, audit-ready actions.

Why the FDA Cybersecurity Update Matters

Today’s connected medical devices interact with:

• Hospital IT networks 
• Cloud-based platforms 
• Mobile applications 
• Other interconnected medical systems 

While this connectivity improves patient care, it also introduces cybersecurity risks, including:

• Unauthorized access 
• Malware attacks 
• Data breaches 
• System manipulation 

The U.S. Food and Drug Administration recognize these risks and now requires manufacturers to treat cybersecurity as a continuous, lifecycle responsibility not a one-time compliance step.

Key Updates in FDA 2025 Cybersecurity Guidance

1. Software Bill of Materials (SBOM)

Manufacturers must now maintain comprehensive SBOM for each device.

Requirements:

• List all software components: 
  • Proprietary 
  • Open source 
  • Third party 
• Identify known vulnerabilities 
• Keep SBOM updated throughout the lifecycle 

Why It Matters:

• Enhances transparency 
• Enables faster vulnerability response 
• Supports regulatory submissions 

2. Continuous Vulnerability Monitoring

The FDA expects real-time risk management, not static assessments.

Key Expectations:

• Monitor emerging vulnerabilities 
• Assess impact on devices 
• Deploy timely patches and updates 
• Communicate risks to users 

Outcome:

• Reduced cybersecurity incidents 
• Improved patient safety 

3. Cybersecurity Labeling Requirements

Device labeling must now include clear cybersecurity information.

Labels Should Specify:

• Connectivity features (network, cloud, Bluetooth, etc.) 
• Duration of security support and updates 
• Contact information for reporting vulnerabilities 
• Instructions for secure device usage 

4. Malware Prevention & Secure Manufacturing

Security must start before the device reaches the market.

FDA Expectations:

• Devices must be free from malware at release 
• Secure development and manufacturing environments 
• Pre-release security validation and testing 

What This Means for Medical Device Manufacturers

The 2025 update significantly raises compliance expectations:

Operational Impact:

• More detailed documentation requirements 
• Expanded testing and validation processes 
• Integration of cybersecurity into Quality Management Systems (QMS) 
• Stronger supplier and third-party risk management 

Strategic Impact:

• Increased development timelines 
• Higher compliance investment 
• Greater focus on lifecycle risk management 

Core Compliance Areas You Must Address

Common Challenges Companies Face

• Lack of SBOM tools and processes 
• Limited cybersecurity expertise in regulatory teams 
• Fragmented data across systems 
• Difficulty aligning suppliers with cybersecurity expectations 
• Managing post-market updates efficiently 

Best Practices for FDA Cybersecurity Compliance

1. Integrate Cybersecurity into QMS

• Make cybersecurity part of daily operations 
• Align with risk management frameworks 

2. Build a Robust SBOM Framework

• Use automated tools 
• Maintain real-time updates 

3. Strengthen Security Testing

• Perform: 
  • Penetration testing 
  • Vulnerability assessments 
  • Software validation 

4. Enhance Supplier Risk Management

• Define cybersecurity requirements for vendors 
• Monitor third-party software risks 

5. Implement Continuous Monitoring Systems

• Real-time threat detection 
• Rapid incident response protocols 

Emerging Trends in Medical Device Cybersecurity

• AI-driven threat detection 
• Automated SBOM generation tools 
• Integration with DevSecOps frameworks 
• Increased regulatory alignment across global markets 
• Cybersecurity as a competitive differentiator 

Why This Matters

Non-compliance with FDA cybersecurity guidance can lead to:

• Regulatory delays or rejections 
• Product recalls 
• Patient safety risks 
• Reputational damage 

Benefits of Compliance:

• Faster regulatory approvals 
• Enhanced patient trust 
• Stronger product security 
• Long-term business resilience 

Maven’s Practical Approach to FDA Cybersecurity Compliance

Our Services:

Gap Analysis

• Identify gaps between current processes and FDA requirements 
• Deliver actionable compliance roadmap 

QMS Integration

• Embed cybersecurity into quality systems 
• Ensure audit readiness 

Security Testing Enhancement

• Expand and automate testing strategies 
• Reduce compliance risks 

SBOM Implementation

• Build and maintain scalable SBOM systems 
• Ensure continuous updates 

Supplier Compliance Management

• Define and enforce cybersecurity standards 
• Strengthening supply chain security 

Regulatory Submissions

• Prepare complete, FDA-ready documentation 
• Clearly demonstrate cybersecurity controls 

Why Choose Maven Regulatory Solutions

• Deep expertise in FDA medical device regulations 
• Strong understanding of cybersecurity frameworks 
• Practical, implementation-focused approach 
• End-to-end support from development to post-market 

Act Now

Cybersecurity is evolving and so are regulatory expectations.

Delaying action can:

• Put your product at risk 
• Delay market entry 
• Increase compliance costs 

Partner with Maven

Ready to align with FDA 2025 cybersecurity requirements?

Maven helps you:

• Simplify compliance 
• Strengthening product security 
• Accelerate approvals 

Conclusion

The FDA’s 2025 cybersecurity guidance marks a shift toward proactive, lifecycle-based security management in medical devices.

By focusing on:

• SBOM transparency 
• Continuous monitoring 
• Secure design and manufacturing 
• Clear user communication 

Manufacturers can not only meet regulatory expectations but also build safer, more resilient devices.

With Maven Regulatory Solutions as your partner, you can confidently navigate these changes and turn compliance into a strategic advantage.

FAQs

1. What is the FDA 2025 cybersecurity update?

A guidance requiring lifecycle-based cybersecurity for medical devices.

2. What is SBOM?

A list of all software components in a device.

3. Is cybersecurity labeling mandatory?

Yes, devices must include user-facing security information.

4. What is continuous monitoring?

Ongoing tracking and management of vulnerabilities.

5. Does this apply to the post-market?

Yes, lifecycle cybersecurity includes post-market updates.

6. What are the risks of non-compliance?

Regulatory delays, recalls, and safety risks.

7. How can Maven help?

By providing end-to-end cybersecurity compliance support.